People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Caliper Life Sciences Inc | — | Biotechnology | Series A | $10.8M | $390.2M | 2010 |
Van A. Billet at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Van A. Billet on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| E. Kevin Hrusovsky | 1 | 2 |
| Peter F. McAree | 1 | 1 |
| David A. Milligan, Ph.D. | 1 | 1 |
| Stephen E. Creager | 1 | 1 |
| Allan L. Comstock | 1 | 1 |
| Robert C. Bishop, Ph.D. | 1 | 1 |
| Kathryn A. Tunstall | 1 | 1 |
| David C. Carter | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.